EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study

Fahimeh Ramezani Tehrani iD, Maryam Mousavi iD, Marzieh Saei Ghare Naz iD, Maryam Farahmand iD, Masoumeh Jorjani iD, Fatemeh Mahboobifard iD

Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)

DOI: 10.1002/edm2.70287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 30.07.2026. Verfasst von Fahimeh Ramezani Tehrani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beh…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Anti-Mullerian Hormone. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Department of the School of Medicine, Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Evidence regarding age‐related variation in anti‐Müllerian hormone (AMH) and its associations with hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS), healthy women, and those with isolated PCOS features remains inconsistent. This study aimed to address these gaps using a cross‐sectional, population‐based approach.

Methods

A total of 883 women aged 18–45 years were categorized into three groups: PCOS ( n = 124; Rotterdam criteria), suspicious (one PCOS criterion, n = 274), and healthy controls ( n = 485). The coefficient of determination (R 2 ) assessed age‐related AMH variation. Linear regression evaluated associations between AMH and hormonal and metabolic profiles. Age‐stratified multivariable logistic regression, adjusted for BMI, parity, and physical activity, examined associations between AMH and type 2 diabetes (T2DM), hypertension, metabolic syndrome (MetS), and dyslipidemia.

Results

Age explained nearly 40% of AMH variation in healthy women, but only 20% in those with PCOS. AMH was inversely correlated with BMI in healthy and suspicious groups, but not in PCOS. Among healthy women aged ≥ 35 years, higher AMH was associated with a 37% reduced likelihood of T2DM (OR: 0.63, 95% CI: 0.41–0.97). In contrast, among women with PCOS aged < 35 years, elevated AMH was associated with 2.6‐fold higher odds of MetS (OR: 2.6, 95% CI: 1.20–6.20). In the suspicious group, AMH correlated positively with free androgen index and prolactin.

Conclusion

AMH declines less with age in women with PCOS than in healthy women. Higher AMH may be protective against T2DM in older healthy women but indicates elevated metabolic risk in younger women with PCOS, suggesting that AMH may serve as a life‐course biomarker for metabolic risk stratification and personalized preventive strategies in women's healthcare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAnti-Mullerian HormoneHumansFemaleAdultCross-Sectional StudiesYoung AdultAdolescentMiddle AgedMetabolic SyndromeDiabetes Mellitus, Type 2Case-Control StudiesBody Mass IndexBiomarkersAge FactorsHypertension

Stichwörter der Autor:innen

Anti‐Müllerian hormoneMetabolic profilePolycystic ovary syndrome

Substanzen

Anti-Mullerian HormoneBiomarkers

Autor:innen und Institutionen

  • Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Foundation for Research & Education Excellence, Vestavia Hills, Alabama, USA.
  • Department of Pharmacology, School of Medicine & Neurobiology Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Fahimeh Ramezani Tehrani, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Masoumeh Jorjani, Fatemeh Mahboobifard

Förderung

  • Research Department of the School of Medicine, Shahid Beheshti University of Medical Sciences

Zitieren

APA

Ramezani Tehrani, F., Mousavi, M., Saei Ghare Naz, M., Farahmand, M., Jorjani, M., & Mahboobifard, F. (2026). Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70287

Vancouver

Ramezani Tehrani F, Mousavi M, Saei Ghare Naz M, Farahmand M, Jorjani M, Mahboobifard F. Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70287

BibTeX
@article{RamezaniTehrani2026,
  author = {Ramezani Tehrani, Fahimeh and Mousavi, Maryam and Saei Ghare Naz, Marzieh and Farahmand, Maryam and Jorjani, Masoumeh and Mahboobifard, Fatemeh},
  title = {Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {5},
  doi = {10.1002/edm2.70287}
}
Kostenlos starten →